We are live on ! Find out more
FFA

Farther Finance Advisors Portfolio holdings

AUM $12.8B
1-Year Est. Return 26.53%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+26.53%
3 Year Est. Return
+74.11%
5 Year Est. Return
10 Year Est. Return
AUM
$1.39B
AUM Growth
+$753M
Cap. Flow
+$659M
Cap. Flow %
47.43%
Top 10 Hldgs %
30.1%
Holding
3,660
New
1,034
Increased
1,765
Reduced
404
Closed
103

Sector Composition

Rank Sector Weight
1 Technology 11.42%
2 Financials 4.56%
3 Healthcare 3.91%
4 Consumer Discretionary 3.2%
5 Industrials 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLIO icon
3201
Helios Technologies
HLIO
$2.76B
$227 ﹤0.01%
+5
New +$231
VREX icon
3202
Varex Imaging
VREX
$523M
$226 ﹤0.01%
+11
New +$210
VTOL icon
3203
Bristow Group
VTOL
$1.36B
$226 ﹤0.01%
+8
New +$216
SHO icon
3204
Sunstone Hotel Investors
SHO
$2.06B
$225 ﹤0.01%
21
-279
-93% -$2.75K
FDMT icon
3205
4D Molecular Therapeutics
FDMT
$562M
$223 ﹤0.01%
+11
New +$145
VERV
3206
DELISTED
Verve Therapeutics
VERV
$223 ﹤0.01%
16
+14
+700% +$174
SMLR
3207
DELISTED
Semler Scientific
SMLR
$221 ﹤0.01%
+5
New +$180
RVNC
3208
DELISTED
Revance Therapeutics, Inc.
RVNC
$220 ﹤0.01%
+25
New +$205
ACCO icon
3209
Acco Brands
ACCO
$407M
$219 ﹤0.01%
36
+8
+29% +$42
FC icon
3210
Franklin Covey
FC
$246M
$218 ﹤0.01%
+5
New +$198
USRT icon
3211
iShares Core US REIT ETF
USRT
$4.64B
$217 ﹤0.01%
+4
New +$196
KURA icon
3212
Kura Oncology
KURA
$850M
$216 ﹤0.01%
+15
New +$147
ALT icon
3213
Altimmune
ALT
$599M
$214 ﹤0.01%
+19
New +$79
IIIV icon
3214
i3 Verticals
IIIV
$342M
$212 ﹤0.01%
+10
New +$201
RUSHB icon
3215
Rush Enterprises Class B
RUSHB
$6.14B
$212 ﹤0.01%
4
PRCT icon
3216
Procept Biorobotics
PRCT
$1.17B
$210 ﹤0.01%
5
LEXX icon
3217
Lexaria Bioscience
LEXX
$8.71M
$208 ﹤0.01%
11
WTS icon
3218
Watts Water Technologies
WTS
$13.1B
$208 ﹤0.01%
+1
New +$189
CYH icon
3219
Community Health Systems
CYH
$423M
$207 ﹤0.01%
66
HCSG icon
3220
Healthcare Services Group
HCSG
$1.53B
$207 ﹤0.01%
+20
New +$200
LQDT icon
3221
Liquidity Services
LQDT
$1.32B
$207 ﹤0.01%
+12
New +$228
KYMR icon
3222
Kymera Therapeutics
KYMR
$8.94B
$204 ﹤0.01%
+8
New +$143
SRTA
3223
Strata Critical Medical Inc
SRTA
$512M
$201 ﹤0.01%
+57
New +$164
FBK icon
3224
FB Financial Corp
FBK
$3.04B
$199 ﹤0.01%
+5
New +$166
PRIM icon
3225
Primoris Services
PRIM
$4.45B
$199 ﹤0.01%
6
-36
-86% -$1.12K

Similar funds

Farther Finance Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Farther Finance Advisors held 3,660 positions worth $1.39B, up 118% from $637M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Farther Finance Advisors deployed $659M of net new capital in Q4 2023, opening 1,034 new positions and adding to 1,765 existing holdings. Its largest new stake was Vanguard Morningstar Mega Cap ETF: 40,505 shares worth $6.86M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $1.46M trimmed.

  • Farther Finance Advisors's largest Q4 2023 buy was Vanguard Morningstar Mega Cap ETF: 40,505 shares worth $6.86M.
  • Farther Finance Advisors added most to Vanguard S&P 500 ETF in Q4 2023, an estimated $74M increase.
  • Farther Finance Advisors's biggest Q4 2023 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.46M.
  • Farther Finance Advisors fully exited Invesco BulletShares 2023 High Yield Corporate Bond ETF in Q4 2023, selling an estimated $337K.
  • Farther Finance Advisors's ten largest holdings make up 30% of its $1.39B portfolio in Q4 2023.
  • Farther Finance Advisors opened 1,034 new positions and closed 103 in Q4 2023.
  • Farther Finance Advisors's portfolio value rose 118% quarter-over-quarter to $1.39B.

Based on Farther Finance Advisors's 13F filing for Q4 2023, filed 15 Feb 2024.